[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Christopher D. Payne, a director of Hims & Hers Health, Inc. (HIMS), was granted 3,656 Restricted Stock Units (RSUs) on 08/06/2025. Each RSU represents a contingent right to receive one share of Class A common stock, and the reported beneficial ownership following the grant is 3,656 shares held directly.

The RSUs vest upon the earlier of the company’s 2026 annual meeting of stockholders or June 15, 2026, and are subject to continuous service. The award carries no exercise price and converts one-for-one into Class A common stock when vested, increasing the director’s direct equity stake but remaining subject to standard service and vesting conditions.

Insights

Financial Analyst

TL;DR: Small, routine RSU grant to a director; aligns incentives but is unlikely to be material to valuation.

The grant of 3,656 RSUs is a modest equity award for a board member and represents contingent rights to the same number of Class A shares. Because the award vests based on continued service and a meeting-based milestone, it functions primarily as retention and alignment compensation. Given the absolute size reported, the transaction is not likely material to company financials or share count.

Corporate Governance Expert

TL;DR: Standard director equity award with time/meeting-based vesting; supports alignment without immediate dilution.

The RSUs vest on the earlier of the 2026 annual meeting or June 15, 2026, subject to continuous service, which is a common governance practice to retain directors and align their interests with shareholders. The award is reported as direct ownership and carries no exercise price, converting one-for-one into Class A common stock upon vesting. This structure is routine and presents typical governance characteristics rather than material governance change.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Payne Christopher D

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/06/2025		A		3,656		(1)	(1)	Class A Common Stock	3,656	$0	3,656	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HIMS report on the Form 4 for Christopher D. Payne?

The Form 4 reports a grant of 3,656 Restricted Stock Units (RSUs) to Christopher D. Payne, a director of Hims & Hers Health, Inc.

When was the RSU grant dated for the HIMS Form 4?

The transaction date listed for the RSU grant is 08/06/2025.

What are the vesting terms for the RSUs reported by HIMS (HIMS)?

The RSUs vest on the earlier of the company’s 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service.

How many shares will the RSUs convert into for HIMS (HIMS)?

Each RSU represents a contingent right to receive one share of Class A common stock, so the grant converts to 3,656 shares upon vesting.

Is the reported ownership direct or indirect for the HIMS RSU grant?

The reported ownership form for the RSUs is Direct (D).